Process Technology. Regardless of anything to the contrary, all processes, recipes, and manufacturing, fabrication, assembly and test techniques, and related improvements (“process technology”) provided and/or developed by or on behalf of Seller or Manufacturer shall be wholly owned by and the property of Seller and Manufacturer, and Seller and Manufacturer shall not be limited or restricted by this Agreement with respect to any process technology unless clearly stated to the contrary in a writing signed by an Officer of Manufacturer identifying the specific information in precise detail.
Process Technology. (i) The Parties will jointly make available to Flash Forward the process technology developed under the JMDY Agreement, the Product Development Agreement or the Common R&D Agreement and applicable to the manufacturing and testing of NAND Flash Memory Products and R/W (“Process Technology”) on a mutually agreed schedule.
(ii) Transfers of Process Technology and process integration for new processes developed pursuant to the JMDY Agreement and that appear on the JMDY Roadmap (as defined in the JMDY Agreement), including those processes developed at AMC or any other facility in accordance with the JMDY Agreement, will be jointly reviewed and discussed by the Parties and will be made in a mutually satisfactory manner. All process integration for new process originating from AMC will be led by Toshiba employees, to the extent reasonably possible. Toshiba and SanDisk will cause their respective employees to cooperate in achieving an efficient transition from development module to operating process and volume production.
(iii) The transfer of Process Technology to JV Space shall be deemed complete when the transferred Process Technology passes a reasonable qualification procedure to be mutually agreed upon by the Parties.
(iv) [***]
(v) [***]
Process Technology. 2.1.1 APT shall provide Siemens with the design information for each Process as more fully described in EXHIBIT 3 for the purpose of specifying the Process in accordance with Section 2.1.2.
2.1.2 APT and Siemens shall agree upon Process specifications to be described in Exhibit 3, which shall be finalized before Siemens begins production in accordance with Section 3.
2.1.3 Subject to the stipulations and procedure set forth in this Agreement and in accordance with the qualification plan described in Exhibit 5 Siemens shall bring up the Process which shall meet the specification in Exhibit 3 and deliver the required Wafers for qualification purposes.
Process Technology. ABX shall own all ABX Process Technology; provided, however, that, on and after the designation of a Candidate Drug that binds to and is directed against a Collaboration Antigen, AZ shall own, and ABX and its Affiliates shall assign to AZ, the Manufacturing Data and any cell lines, including research and master cell banks, expressing Candidate Drugs, Licensed Products or other Antibodies that bind to and are directed against such Collaboration Antigen. Subject to the process development and manufacturing and supply commitments set forth in this Article 7 and in the Process Science/Clinical Manufacture Agreement and the Manufacturing and Supply Agreement, ABX and its Affiliates shall grant to AZ a [Confidential treatment requested] worldwide, right and license (with the right to grant sublicenses through multiple tiers of sublicensees subject to the last sentence of this Section 7.9) under the ABX Process Patent Rights and ABX Process Know-How Rights to Exploit Antibodies, Candidate Drugs and Licensed Products for which ABX is performing activities under the Process Science/Clinical Manufacture Agreement for use in the Commercial Field. From and after the date that ABX ceases to perform process development or manufacturing and supply activities with respect to an Antibody, a Candidate Drug or a Licensed Product under the Process Science/Clinical Manufacture Agreement and the Manufacturing and Supply Agreement, ABX and its Affiliates shall grant to AZ the exclusive, worldwide, [Confidential treatment requested] right and license (with the right to grant sublicenses through multiple tiers of sublicensees subject to the last sentence of this Section 7.9) under the ABX Process Patent Rights and ABX Process Know-How Rights to Exploit such Antibody, Candidate Drug and Licensed Product for use in the Commercial Field. Notwithstanding anything to the contrary in this Agreement, the right of AZ to grant sublicenses under the ABX Process Patent Rights and ABX Process Know-How Rights applicable to an Antibody, Candidate Drug or Licensed Product shall be limited solely to the extent Reasonably Necessary to manufacture and supply such Antibody, Candidate Drug or Licensed Product for use in the Commercial Field (and related process development and testing activities).
Process Technology. In no event may Conexant or any Conexant Affiliate sublicense any Licensed Patent or Transferred Know-How to any third party for the purpose of enabling such third party to provide semiconductor fabrication services (or similar services) to anyone other than Conexant or Conexant Affiliates.
Process Technology. Subject to the license grants to AZ under this Agreement, as between the Parties, ABX shall own and retain all right, title and interest in and to all of the ABX Process Technology (together with all Patent Rights and other intellectual property rights therein). AZ shall own and retain all right, title and interest in and to all of the AZ Process Technology (together with all Patent Rights and other intellectual property rights therein).
Process Technology. 2.1.1 APT shall provide EPISIL with the design information for each Process as described in Exhibit 2 for the purpose of specifying the Process in accordance with Section 2.1.2.
2.1.2 Both parties agree that technology transfer and qualification will proceed first on APT’s [*] products / process with the intent that Processes are qualified for each technology listed in Exhibit 5 within [*] months of the date this Agreement is executed. APT and EPISIL shall agree upon Process specifications to be described in Exhibit 3, which shall be finalized before EPISIL begins production in accordance with Section 3. Subject to the stipulations and procedures set forth in this Agreement and in accordance with the qualification plan described in Exhibit 4, EPISIL shall install the Processes meeting the specifications in Exhibit 3 and deliver Wafers for qualification purposes.
Process Technology. 2.1.1. APT shall provide CSMC with the process / design information for each Process step as described in Exhibit 2 for the purpose of specifying the Process in accordance with Section 2.1.2.
2.1.2. Both parties agree that technology transfer and qualification will proceed first on APT’s Mosfet Mos8 products / technology with the intent that the Process is qualified within six to nine (6-9) months of the date this Agreement is executed.
2.1.3. CSMC agrees to assign a dedicated customer engineer to APT for the duration of this agreement.
2.1.4. APT and CSMC shall agree upon Process specifications to be documented in Exhibit 3, which shall be finalized before CSMC begins production in accordance with Section 3. [ * ] = CONFIDENTIAL TREATMENT REQUESTED APT / CSMC Foundry Agreement
2.1.5. Subject to the stipulations and procedures set forth in this Agreement and in accordance with the qualification plan CSMC shall install the Processes meeting the specifications in Exhibit 3 and deliver Wafers for qualification purposes.
Process Technology. 3.1 Xicor will provide to Sanyo the Xicor C5 and C7 process flows, process parameters, design rules and other relevant information to enable Wafers and Devices to be manufactured by Sanyo. It is understood that the information listed above is the Proprietary Information of Xicor and will remain the sole property of Xicor. Nothing in
Process Technology. 3.1 Xicor will provide to Yamaha the Xicor C5 process flow, process parameters, design rules and other relevant information to enable Wafers and Devices to be manufactured by Yamaha. It is understood that the information listed above is the
